Aptorum Group Limited (NASDAQ:APM) Sees Significant Growth in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 184,800 shares, a growth of 1,564.9% from the December 31st total of 11,100 shares. Based on an average trading volume of 2,190,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.7% of the shares of the company are short sold.

Aptorum Group Price Performance

Shares of NASDAQ:APM traded down $0.15 during trading on Tuesday, hitting $1.10. 213,151 shares of the stock traded hands, compared to its average volume of 1,177,477. The company has a fifty day moving average price of $1.07 and a two-hundred day moving average price of $1.98. Aptorum Group has a 52-week low of $0.46 and a 52-week high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.